Substantial studies have shown that hypoxia is responsible for the immune suppression of the tumour microenvironment by hypoxia-induced HIF-1α and adenosine release in cancer cells and the inhibition of immune cell function by increasing the amount of adenosine A2A receptors (A2ARs)31–33. The gene discussed is ADORA2A; the disease is neoplasm.